• 1. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 2. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 3. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 4. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 5. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860

Introduction to (Z)-N'-hydroxycyclopent-1-carboximidamide (CAS No. 99623-12-8)

Compound (Z)-N'-hydroxycyclopent-1-carboximidamide, identified by its Chemical Abstracts Service registry number CAS No. 99623-12-8, is a significant molecule in the realm of chemical and pharmaceutical research. This compound belongs to the class of imidamides, which have garnered considerable attention due to their diverse biological activities and potential applications in drug development.

The structure of (Z)-N'-hydroxycyclopent-1-carboximidamide features a cyclopentane ring substituted with a carboximidamide functional group. The (Z) configuration indicates the spatial arrangement of the substituents around the double bond, which is a critical factor in determining its pharmacological properties. This specific configuration often enhances the binding affinity and selectivity of the compound towards biological targets.

In recent years, there has been growing interest in imidamide derivatives due to their role as intermediates in the synthesis of various therapeutic agents. The hydroxyl group in (Z)-N'-hydroxycyclopent-1-carboximidamide makes it a versatile precursor for further functionalization, enabling the development of novel compounds with tailored biological activities.

One of the most compelling aspects of (Z)-N'-hydroxycyclopent-1-carboximidamide is its potential as a pharmacophore in medicinal chemistry. The cyclopentane ring provides a rigid scaffold that can interact favorably with biological targets, while the carboximidamide moiety offers multiple sites for chemical modification. These features make it an attractive candidate for designing drugs targeting various diseases, including inflammatory disorders and infectious diseases.

Recent studies have highlighted the importance of imidamides in drug discovery. For instance, researchers have demonstrated that certain imidamide derivatives exhibit potent anti-inflammatory properties by inhibiting key enzymes involved in the inflammatory cascade. The hydroxyl group in (Z)-N'-hydroxycyclopent-1-carboximidamide is particularly noteworthy, as it can be exploited to develop prodrugs or analogs with improved pharmacokinetic profiles.

The synthesis of (Z)-N'-hydroxycyclopent-1-carboximidamide involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies, such as transition metal-catalyzed cross-coupling reactions and asymmetric hydrogenation, have been employed to achieve high yields and enantioselectivity. These synthetic strategies are crucial for producing sufficient quantities of the compound for both research and potential clinical applications.

From a computational chemistry perspective, molecular modeling studies have been instrumental in understanding the binding mode of (Z)-N'-hydroxycyclopent-1-carboximidamide to its target proteins. These studies have revealed that the compound interacts with key residues through hydrogen bonding and hydrophobic interactions, providing insights into its mechanism of action. Such information is invaluable for optimizing the compound's potency and selectivity.

The pharmaceutical industry has shown considerable interest in developing new drugs based on imidamide scaffolds. Several clinical trials are currently underway evaluating the efficacy and safety of imidamide derivatives in treating various conditions. The success of these trials could pave the way for (Z)-N'-hydroxycyclopent-1-carboximidamide to be used as a lead compound or intermediate in future drug development efforts.

In conclusion, (Z)-N'-hydroxycyclopent-1-carboximidamide (CAS No. 99623-12-8) is a promising compound with significant potential in pharmaceutical research. Its unique structural features and biological activities make it an attractive candidate for further investigation and development. As research continues to uncover new applications for this compound, it is likely to play an important role in the discovery and development of novel therapeutic agents.

• 45179-53-1(Decanediimidamide,N1,N10-dihydroxy-)
• 648440-40-8(Tetradecanediimidamide, N,N''-dihydroxy-, dihydrochloride)
• 5693-86-7(Pentanediimidamide,N,N''-dihydroxy- (9CI))
• 1562981-98-9(2-cyclobutyl-N'-hydroxyethanimidamide)
• 2384715-22-2(N',3-dihydroxycyclobutanecarboximidamide)
• 857653-90-8(Cyclohexanecarboximidamide, N-hydroxy-4-pentyl-, trans-)
• 159458-42-1(TRIDECANIMIDAMIDE, N-HYDROXY-)
• 188719-94-0(Pentanimidamide, N-hydroxy-3-methyl-)
• 1025251-55-1(Butanimidamide, N-hydroxy-2-methyl-)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)